A comprehensive review on COVID-19 with main focus on management and treatment options

Medicine and Dentistry

• COVID-19 100%
• Infection 66%
• Disease 66%
• Severe Acute Respiratory Syndrome Coronavirus 2 66%
• Drug Therapy 33%
• Headache 33%
• Dyspnea 33%
• Coughing 33%
• Lung Lavage 33%
• Diagnosis 33%
• Population 33%
• Public Health 33%
• Real Time Polymerase Chain Reaction 33%
• Sore Throat 33%
• Nausea 33%
• Clinical Trial 33%
• Flu Like Syndrome 33%
• Gastrointestinal Distress 33%
• Assisted Ventilation 33%
• Antivirus Agent 33%
• SARS Coronavirus 33%
• Coronavirinae 33%
• Middle East Respiratory Syndrome Coronavirus 33%
• COVID-19 Therapy 33%
• Nose Smear 33%
• Spanish Influenza 33%
• Interleukin 6 33%

INIS

• management 100%
• reviews 100%
• coronaviruses 100%
• covid-19 100%
• diseases 60%
• risks 40%
• devices 40%
• humans 40%
• symptoms 40%
• vaccines 40%
• people 20%
• populations 20%
• therapy 20%
• interventions 20%
• surfaces 20%
• clinical trials 20%
• public health 20%
• influenza 20%
• world health organization 20%
• capacity 20%
• lavage 20%
• nose 20%
• steroids 20%
• throat 20%
• fatigue 20%
• nausea 20%
• polymerase chain reaction 20%
• middle east 20%
• quarantine 20%

Pharmacology, Toxicology and Pharmaceutical Science

• SARS Coronavirus 100%
• Disease 100%
• Infection 66%
• Coronavirinae 66%
• Clinical Trial 33%
• Antivirus Agent 33%
• Pandemic 33%
• Coughing 33%
• Headache 33%
• Gastrointestinal Symptom 33%
• Nausea 33%
• Sore Throat 33%
• Middle East Respiratory Syndrome Coronavirus 33%
• Flu Like Syndrome 33%
• Spanish Influenza 33%
• Interleukin 6 33%
• Dyspnea 33%